Informatie:
Fout:
ID
34308
Beschrijving
Evaluation of CLP With and Without Spironolactone in Heart Failure Patients With Chronic Kidney Disease; ODM derived from: https://clinicaltrials.gov/show/NCT01598740
Link
https://clinicaltrials.gov/show/NCT01598740
Trefwoorden
Versies (1)
- 16-01-19 16-01-19 -
Houder van rechten
see on clinicaltrials.gov
Geüploaded op
16 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Heart Failure NCT01598740
Eligibility Heart Failure NCT01598740
- StudyEvent: Eligibility
Similar models
Eligibility Heart Failure NCT01598740
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
heart failure with new york heart association (nyha) classification ii or iii
boolean
ID.2
Item
chronic kidney disease
boolean
ID.3
Item
cardiac ejection fraction <40%
boolean
ID.4
Item
on heart failure therapy including an acei or arb, and a bb
boolean
ID.5
Item
willing to understand and comply with study procedures and provide written informed consent.
boolean
ID.6
Item
hospitalization within 4 weeks of baseline visit
boolean
ID.7
Item
history or presence of gastrointestinal conditions such as severe constipation or gastrointestinal tract strictures
boolean
ID.8
Item
current or anticipated dialysis during study
boolean
ID.9
Item
in the investigator's judgment, any cardiovascular, renal, hepatic, endocrine, gastrointestinal, neurological, or other disease or condition that makes the subject's study participation unsafe
boolean
ID.10
Item
drug or alcohol abuse
boolean